130 related articles for article (PubMed ID: 35750276)
41. ATR kinase inhibition induces unscheduled origin firing through a Cdc7-dependent association between GINS and And-1.
Moiseeva T; Hood B; Schamus S; O'Connor MJ; Conrads TP; Bakkenist CJ
Nat Commun; 2017 Nov; 8(1):1392. PubMed ID: 29123096
[TBL] [Abstract][Full Text] [Related]
42. Chk1 inhibits replication factory activation but allows dormant origin firing in existing factories.
Ge XQ; Blow JJ
J Cell Biol; 2010 Dec; 191(7):1285-97. PubMed ID: 21173116
[TBL] [Abstract][Full Text] [Related]
43. Multi-Level Control of the ATM/ATR-CHK1 Axis by the Transcription Factor E4F1 in Triple-Negative Breast Cancer.
Batnini K; Houles T; Kirsh O; Du Manoir S; Zaroual M; Delpech H; Fallet C; Lacroix M; Le Cam L; Theillet C; Sardet C; Rodier G
Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012478
[No Abstract] [Full Text] [Related]
44. UV-induced ataxia-telangiectasia-mutated and Rad3-related (ATR) activation requires replication stress.
Ward IM; Minn K; Chen J
J Biol Chem; 2004 Mar; 279(11):9677-80. PubMed ID: 14742437
[TBL] [Abstract][Full Text] [Related]
45. Dbf4 is direct downstream target of ataxia telangiectasia mutated (ATM) and ataxia telangiectasia and Rad3-related (ATR) protein to regulate intra-S-phase checkpoint.
Lee AY; Chiba T; Truong LN; Cheng AN; Do J; Cho MJ; Chen L; Wu X
J Biol Chem; 2012 Jan; 287(4):2531-43. PubMed ID: 22123827
[TBL] [Abstract][Full Text] [Related]
46. The human oncoprotein MDM2 induces replication stress eliciting early intra-S-phase checkpoint response and inhibition of DNA replication origin firing.
Frum RA; Singh S; Vaughan C; Mukhopadhyay ND; Grossman SR; Windle B; Deb S; Deb SP
Nucleic Acids Res; 2014 Jan; 42(2):926-40. PubMed ID: 24163099
[TBL] [Abstract][Full Text] [Related]
47. A balanced pyrimidine pool is required for optimal Chk1 activation to prevent ultrafine anaphase bridge formation.
Gemble S; Buhagiar-Labarchède G; Onclercq-Delic R; Biard D; Lambert S; Amor-Guéret M
J Cell Sci; 2016 Aug; 129(16):3167-77. PubMed ID: 27383768
[TBL] [Abstract][Full Text] [Related]
48. Stalled replication induces p53 accumulation through distinct mechanisms from DNA damage checkpoint pathways.
Ho CC; Siu WY; Lau A; Chan WM; Arooz T; Poon RY
Cancer Res; 2006 Feb; 66(4):2233-41. PubMed ID: 16489026
[TBL] [Abstract][Full Text] [Related]
49. ZEB1 inhibition sensitizes cells to the ATR inhibitor VE-821 by abrogating epithelial-mesenchymal transition and enhancing DNA damage.
Song N; Jing W; Li C; Bai M; Cheng Y; Li H; Hou K; Li Y; Wang K; Li Z; Liu Y; Qu X; Che X
Cell Cycle; 2018; 17(5):595-604. PubMed ID: 29157079
[TBL] [Abstract][Full Text] [Related]
50. WRN helicase regulates the ATR-CHK1-induced S-phase checkpoint pathway in response to topoisomerase-I-DNA covalent complexes.
Patro BS; Frøhlich R; Bohr VA; Stevnsner T
J Cell Sci; 2011 Dec; 124(Pt 23):3967-79. PubMed ID: 22159421
[TBL] [Abstract][Full Text] [Related]
51. Evidence that the ATR/Chk1 pathway maintains normal replication fork progression during unperturbed S phase.
Petermann E; Caldecott KW
Cell Cycle; 2006 Oct; 5(19):2203-9. PubMed ID: 16969104
[TBL] [Abstract][Full Text] [Related]
52. The Replication Checkpoint Prevents Two Types of Fork Collapse without Regulating Replisome Stability.
Dungrawala H; Rose KL; Bhat KP; Mohni KN; Glick GG; Couch FB; Cortez D
Mol Cell; 2015 Sep; 59(6):998-1010. PubMed ID: 26365379
[TBL] [Abstract][Full Text] [Related]
53. Participation of the ATR/CHK1 pathway in replicative stress targeted therapy of high-grade ovarian cancer.
Gralewska P; Gajek A; Marczak A; Rogalska A
J Hematol Oncol; 2020 Apr; 13(1):39. PubMed ID: 32316968
[TBL] [Abstract][Full Text] [Related]
54. Marek's Disease Virus Disables the ATR-Chk1 Pathway by Activating STAT3.
Lian X; Bao C; Li X; Zhang X; Chen H; Jung YS; Qian Y
J Virol; 2019 May; 93(9):. PubMed ID: 30787154
[TBL] [Abstract][Full Text] [Related]
55. DNA damage checkpoint kinases in cancer.
Smith HL; Southgate H; Tweddle DA; Curtin NJ
Expert Rev Mol Med; 2020 Jun; 22():e2. PubMed ID: 32508294
[TBL] [Abstract][Full Text] [Related]
56. A Tale of Two Checkpoints: ATR Inhibition and PD-(L)1 Blockade.
Ngoi NYL; Peng G; Yap TA
Annu Rev Med; 2022 Jan; 73():231-250. PubMed ID: 34644155
[TBL] [Abstract][Full Text] [Related]
57. Critical role of SMG7 in activation of the ATR-CHK1 axis in response to genotoxic stress.
Ho K; Luo H; Zhu W; Tang Y
Sci Rep; 2021 Apr; 11(1):7502. PubMed ID: 33820915
[TBL] [Abstract][Full Text] [Related]
58. Targeting DNA Damage Response in Prostate Cancer by Inhibiting Androgen Receptor-CDC6-ATR-Chk1 Signaling.
Karanika S; Karantanos T; Li L; Wang J; Park S; Yang G; Zuo X; Song JH; Maity SN; Manyam GC; Broom B; Aparicio AM; Gallick GE; Troncoso P; Corn PG; Navone N; Zhang W; Li S; Thompson TC
Cell Rep; 2017 Feb; 18(8):1970-1981. PubMed ID: 28228262
[TBL] [Abstract][Full Text] [Related]
59. ATR prohibits replication catastrophe by preventing global exhaustion of RPA.
Toledo LI; Altmeyer M; Rask MB; Lukas C; Larsen DH; Povlsen LK; Bekker-Jensen S; Mailand N; Bartek J; Lukas J
Cell; 2013 Nov; 155(5):1088-103. PubMed ID: 24267891
[TBL] [Abstract][Full Text] [Related]
60. Distinct but Concerted Roles of ATR, DNA-PK, and Chk1 in Countering Replication Stress during S Phase.
Buisson R; Boisvert JL; Benes CH; Zou L
Mol Cell; 2015 Sep; 59(6):1011-24. PubMed ID: 26365377
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
